UK: Aspire Pharma strengthens specialty pharma offering with acquisition of Cenoté Pharma
Aspire Pharma, a specialty generics business, has supplemented its organic growth with the acquisition of Cenoté Pharma, a category specialist in carnitine deficiencies.
Financial terms...
UK: Ontario Teachers’ joins Nordic Capital as it reinvests in Advanz
Ontario Teachers’ Pension Plan Board, a leading global institutional investor, and healthcare investor, Nordic Capital, have agreed to jointly invest in Advanz Pharma, a...
France: StromaCare appoints Rawadi as CEO
StromaCare, a French biotechnology company pioneering the discovery and development of cancer immunotherapies through stroma modulation, has appointed Georges Rawadi as CEO. He brings...
Switzerland: Bruker accelerates entry into lab automation with Chemspeed acquisition
Nasdaq listed Bruker Corporation, a manufacturer of scientific instruments for molecular and materials research, is acquiring Chemspeed Technologies, a Swiss provider of vendor-agnostic automated...
UK: Kyowa Kirin completes acquisition of Orchard Therapeutics
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has completed the acquisition of all outstanding shares in UK-based Orchard Therapeutics, a gene therapy developer.
The...
InSight: Building the necessary infrastructure for psychedelics
As psychedelic assets move from development to commercialisation over the next five to ten years, the thousands of therapists and clinics required to deliver...
Asia’s supply chains to be tested by Covid-19 vaccine delivery
Steven Beck, head of trade finance at the ADB, explains how the logistical challenges of vaccine distribution will be aided by trade and supply...













